IPSEN PHARMA S.A.S.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 117141
 
  
 
C07K PEPTIDES 5086
 
  
 
C07D HETEROCYCLIC COMPOUNDS 25137
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1237
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 11143
 
  
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 7113
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 5133
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 565
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 4136

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0050,030 COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENTFeb 16, 16Feb 22, 18[A61K, C07K]
2017/0362,275 Growth Hormone Releasing PeptidesAug 29, 17Dec 21, 17[A61K, C07K]
2017/0304,403 METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEJun 29, 17Oct 26, 17[A61K, C07K]
2017/0240,595 Melanocortin Receptor LigandsMay 05, 17Aug 24, 17[C07K]
2017/0143,834 FORMULATION FOR HGH AND RHIGF-1 COMBINATIONSep 30, 16May 25, 17[A61K]
2017/0037,104 Composition and Methods for Stimulating Gastrointestinal MotilityOct 25, 16Feb 09, 17[C07K]
2016/0002,398 Novel Method for Purifying PolyestersFeb 25, 14Jan 07, 16[C08G]
2015/0238,468 THIAZOLE DERIVATIVES FOR TREATING DYSKINESIAS CAUSED BY A CHEMICAL TREATMENTMar 06, 15Aug 27, 15[A61K, C07D]
2013/0317,121 METHOD FOR THE PREPARATION OF PLYMERS WITH VARIED ARCHTECTURE AND AMIDE INITIATIONNov 14, 11Nov 28, 13[A61K]
2007/0244,034 GLP-1 pharmaceutical compositionsDec 29, 06Oct 18, 07[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9918967 Thiazole derivatives for treating dyskinesias caused by a chemical treatmentMar 06, 15Mar 20, 18[A61K, C07D]
9850280 Melanocortin receptor ligandsMay 05, 17Dec 26, 17[A61K, C07K]
9827286 Use of melanocortins to treat insulin sensitivityAug 22, 16Nov 28, 17[A61K, C07K]
9777039 Somatostatin analogs and dimers thereofOct 31, 13Oct 03, 17[A61K, G01N, C07K, A61M]
9758549 Melanocortin receptor ligands modified with hydantoinFeb 29, 16Sep 12, 17[A61K, C07K]
9731027 Somatostatin-dopamine chimeric analogsOct 31, 13Aug 15, 17[A61K, C07C, C07K]
9724397 Sustained release formulations comprising very low molecular weight polymersOct 26, 07Aug 08, 17[A61K, A61F]
9676752 Imidazolidine-2,4-dione derivativesDec 31, 13Jun 13, 17[C07D]
9624529 N-end rule protease activity indication methods and uses thereofJan 27, 15Apr 18, 17[C12Q]
9603942 Somatostatin-dopamine chimeric analogsFeb 05, 15Mar 28, 17[A61K, C07C, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0368,962 Melanocortin Receptor LigandsAbandonedSep 07, 16Dec 22, 16[C07K]
2016/0311,855 Growth Hormone Releasing PeptidesAbandonedJul 07, 16Oct 27, 16[C07K]
2016/0220,637 Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor LigandsAbandonedJan 29, 16Aug 04, 16[A61K]
2016/0206,700 METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEAbandonedJan 18, 16Jul 21, 16[A61K]
2015/0252,092 ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDEAbandonedMay 20, 15Sep 10, 15[C07K]
2015/0252,093 GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANALOGUESAbandonedMay 20, 15Sep 10, 15[C07K]
2015/0175,665 ANALOGUES OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) MODIFIED AT N-TERMINALAbandonedMar 05, 15Jun 25, 15[A61K, C07K]
2015/0111,823 METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEAbandonedOct 27, 14Apr 23, 15[C07K]
2014/0056,977 SOLID PHARMACEUTICAL COMPOSITION CONTAINING 6-OXO-6,7,8,9,10,11-HEXAHYDROCYCLOHEPTA (C)CHROMEN-3-YL SULFAMATE AND POLYMORPHS THEREOFAbandonedAug 01, 13Feb 27, 14[A61K]
8642591 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicamentExpiredMar 06, 07Feb 04, 14[A61K, A01N]
2014/0017,697 METHOD FOR IDENTIFICATION OF PROTEASE ACTIVITY INHIBITORS AND ASSAYING THE PRESENCE OF PROTEASE ACTIVITYAbandonedSep 13, 13Jan 16, 14[C12Q]
2013/0331,324 USE OF MELANOCORTINS TO TREAT DYSLIPIDEMIAAbandonedAug 21, 13Dec 12, 13[A61K]
2013/0237,682 METHOD FOR PREPARING STAR POLYMERSAbandonedNov 14, 11Sep 12, 13[C08G]
2013/0210,751 Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor LigandsAbandonedMar 14, 11Aug 15, 13[C07K]
2013/0039,999 USE OF CLAYS FOR TREATING COELIAC DISEASEAbandonedApr 13, 12Feb 14, 13[A61K, A61P]
8348881 Device for injecting a pharmaceutical active principleExpiredNov 15, 05Jan 08, 13[A61M]
8349797 Ligands of melanocortin receptorsExpiredJul 10, 06Jan 08, 13[A61K, C07K]
2012/0316,201 NOVEL BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AND USE THEREOF AS A MEDICAMENTAbandonedJun 08, 12Dec 13, 12[A61K, C07D, A61P]
2012/0277,151 GLP-1 PHARMACEUTICAL COMPOSITIONSAbandonedJul 09, 12Nov 01, 12[A61K, A61P]
2012/0270,782 FORMULATION FOR HGH AND RHIGF-1 COMBINATIONAbandonedNov 17, 10Oct 25, 12[A61K, A61P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.